Effects of SARS-CoV-2 mutations on immune response
When the public health crisis broke out, most scientists were focused on finding antibodies to neutralize the virus, neglecting the other component of the immune system, the T cells that attack infected cells. At the time, few foresaw how many mutations SARS-CoV-2 would undergo and their effects on white blood cells.
The research team at the Caron Lab, which works to detect new forms of tumour-specific antigens in order to develop cancer vaccines, did see the mutations coming. “We knew the virus would mutate,” said Étienne Caron, assistant professor in the Department of Pathology and Cell Biology at UdeM’s Faculty of Medicine and an expert on the adaptive immune system.
After a call from David Hamelin, a graduate student in Bioinformatics at the University of Victoria, the lab’s team decided to set up a major research project called “Analysis of the mutational landscape of SARS-CoV-2 variants: implications for T-cell-epitope escape and vaccine resistance.”
“David wanted to combine his experience in mass spectrometry with his passion for computer science to study COVID mutations,” said Caron. “Since the work involved considerable genomic sequencing, I suggested he contact Julie Hussin, director of the MHI-OMICS bioinformatics group at the Montreal Heart Institute. He set up the link between Julie, an expert in population genomics, and me, an expert in cancer immunotherapy. From this improbable combination, the project was born.”